Trials / Recruiting
RecruitingNCT07151391
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 86 (estimated)
- Sponsor
- University of Utah · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to learn if the drug guarana improves symptoms of fatigue in patients with neuroendocrine tumors and gynecologic cancers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Guarana | 500 mg oral medication daily |
| DRUG | Placebo | Oral medication daily |
Timeline
- Start date
- 2025-09-03
- Primary completion
- 2027-09-01
- Completion
- 2028-09-01
- First posted
- 2025-09-03
- Last updated
- 2026-02-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07151391. Inclusion in this directory is not an endorsement.